- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01814293
Comparison of Supportive Therapies for Symptom Relief From Pediatric Upper Respiratory Infections (URIs)
Study Overview
Status
Intervention / Treatment
Detailed Description
Study design is a nonblinded randomized controlled trial. It is a survey-based comparison study of pediatric patients presenting to the Emergency Department (ED) with upper respiratory infection (URI) symptoms for which the ED physician has recommended supportive care only (ie. non-prescription symptom relief). Study duration is approximately one year. Subject participation duration is 4 days.
Subjects will be randomized into 2 groups: handheld humidifier group (FDA cleared medical device that uses distilled water) & control group. Both groups may use any supportive modalities desired such as over-the-counter cold medications (OTCs), room air humidifier etc.
Primary study objective is to determine if the use of handheld humidifier improves URI symptom scores (nocturnal cough, parental perception) and/or reduces use of other supportive modalities compared to the control group for the relief of pediatric URI symptoms.
Three surveys will be obtained from all subjects. The initial survey occurs at the time of enrollment (T0). The second and third surveys will be completed by the parent/guardian on line or by phone on the first day after ED visit (T-1) and sometime between the 2nd-4th day after ED visit (T-2). The survey component includes a validated pediatric cough questionnaire with 7 point Likert scale, and a questions regarding any other supportive treatments used for symptom relief (the type, frequency and results).
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
San Francisco, California, United States, 94143
- University of California San Francisco
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ages 0-18 years old
- URI symptoms of less than 1 week duration.
- No new medications prescribed during this ED visit other than antipyretics and refills of routine medications (ie. refills of bronchodilators are OK).
- Symptom severity scores of atleast 3 ("sometimes" on a Likert 7 point scale) on at least 2 survey questions related to symptom scores (cough frequency/severity, effect on the child's sleep, effect on parental sleep, combined symptom severity).
- Parent consenting the child must have two valid forms of contact information (ie. phone number and email address) in order to follow up as needed for completion of 2nd and 3rd surveys.
- Parent consenting the child must have access to internet connection or phone for the following 2-4 days after enrollment.
- Parent consenting the child must be able to fluently read and speak English without the use of aides. This study budget does not allow for multilingual resources.
Exclusion Criteria:
- Chronic pulmonary disease
- Chronic or congenital cardiac disease
- Chronic cough
- Acute pneumonia
- Any patient that will receive a new prescription from this ED visit (antibiotics, inhalers, steroids, etc)
- Any patient currently using a handheld humidifier for this URI.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Handheld humidifier
Study design is a nonblinded randomized controlled comparison study of pediatric patients presenting to the UCSF Emergency Department (ED) with upper respiratory infection (URI) symptoms for which the ED physician has recommended supportive care only (ie.
non-prescription symptom relief).
Subjects will be randomized into 2 groups: handheld humidifier group (FDA cleared medical device that uses distilled water) & control group.
Both groups may use any supportive modalities desired such as over-the-counter cold medications (OTCs), room air humidifier etc. Follow up surveys will be obtained on days 1 and 2 following the ED visit to assess whether then intervention (use of handheld humidifier) improved symptom scores or reduced the use of OTC medications or room humidifier.
|
Subjects will be randomized into 2 groups: handheld humidifier group (FDA cleared medical device that uses distilled water) & control group.
Both groups may use any supportive modalities desired such as over-the-counter cold medications (OTCs), room air humidifier etc. Follow up surveys will be obtained on days 1 and 2 following the ED visit to assess whether then intervention (use of handheld humidifier) improved symptom scores or reduced the use of OTC medications or room humidifier.
Other Names:
|
No Intervention: Control group
Subjects will manage cold symptoms with any desired supportive over the counter treatment, and complete surveys related to symptom scores and modalities used.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
URI (upper respiratory infection) symptoms one day after ED visit
Time Frame: 1 day
|
Differences in symptom scores will be compared between handheld humidifier group and control group based on supportive treatments used.
Proposed outcome is that the humidifier group has improved symptom scores and/or reduced use of other supportive modalities (ie.
cold meds) compared to the control group during the time frame between the ED visit to the following day.
|
1 day
|
URI (upper respiratory infection) symptoms 2 days after ED visit
Time Frame: 1 day
|
Differences in symptom scores will be compared between handheld humidifier group and control group based on supportive treatments used.
Proposed outcome is that the humidifier group has improved symptom scores and/or reduced use of other supportive modalities (ie.
cold meds) compared to the control group during the time frame between the 1st and 2nd days following the ED visit.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
URI (upper respiratory infection) revisits
Time Frame: 2 days
|
Comparison between handheld humidifier group and control group regarding each group's symptom scores and need for revisits for same URI.
Potential additional findings may include reduction of revisits for same URI, parental observed reduction in severity and/or duration of illness.
|
2 days
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jacqueline A Nemer, MD, University of California, San Francisco
Publications and helpful links
General Publications
- Gunn VL, Taha SH, Liebelt EL, Serwint JR. Toxicity of over-the-counter cough and cold medications. Pediatrics. 2001 Sep;108(3):E52. doi: 10.1542/peds.108.3.e52.
- Kuehn BM. FDA: cold medications risky for young children. JAMA. 2007 Sep 12;298(10):1151. doi: 10.1001/jama.298.10.1151. No abstract available.
- Vernacchio L, Kelly JP, Kaufman DW, Mitchell AA. Pseudoephedrine use among US children, 1999-2006: results from the Slone survey. Pediatrics. 2008 Dec;122(6):1299-304. doi: 10.1542/peds.2008-0284.
- Lokker N, Sanders L, Perrin EM, Kumar D, Finkle J, Franco V, Choi L, Johnston PE, Rothman RL. Parental misinterpretations of over-the-counter pediatric cough and cold medication labels. Pediatrics. 2009 Jun;123(6):1464-71. doi: 10.1542/peds.2008-0854.
- Paul IM, Yoder KE, Crowell KR, Shaffer ML, McMillan HS, Carlson LC, Dilworth DA, Berlin CM Jr. Effect of dextromethorphan, diphenhydramine, and placebo on nocturnal cough and sleep quality for coughing children and their parents. Pediatrics. 2004 Jul;114(1):e85-90. doi: 10.1542/peds.114.1.e85.
- Centers for Disease Control and Prevention (CDC). Infant deaths associated with cough and cold medications--two states, 2005. MMWR Morb Mortal Wkly Rep. 2007 Jan 12;56(1):1-4.
- Dart RC, Paul IM, Bond GR, Winston DC, Manoguerra AS, Palmer RB, Kauffman RE, Banner W, Green JL, Rumack BH. Pediatric fatalities associated with over the counter (nonprescription) cough and cold medications. Ann Emerg Med. 2009 Apr;53(4):411-7. doi: 10.1016/j.annemergmed.2008.09.015. Epub 2008 Dec 19.
- Rimsza ME, Newberry S. Unexpected infant deaths associated with use of cough and cold medications. Pediatrics. 2008 Aug;122(2):e318-22. doi: 10.1542/peds.2007-3813.
- Daftary AS, Deterding RR. Inhalational lung injury associated with humidifier "white dust". Pediatrics. 2011 Feb;127(2):e509-12. doi: 10.1542/peds.2010-1312. Epub 2011 Jan 3.
- Muller-Wening D, Koschel D, Stark W, Sennekamp HJ. [Humidifier-associated disease in the general population]. Dtsch Med Wochenschr. 2006 Mar 10;131(10):491-6. doi: 10.1055/s-2006-932548. German.
- Baur X, Behr J, Dewair M, Ehret W, Fruhmann G, Vogelmeier C, Weiss W, Zinkernagel V. Humidifier lung and humidifier fever. Lung. 1988;166(2):113-24. doi: 10.1007/BF02714035.
- Wallis BA, Turner J, Pearn J, Kimble RM. Scalds as a result of vapour inhalation therapy in children. Burns. 2008 Jun;34(4):560-4. doi: 10.1016/j.burns.2007.07.016. Epub 2007 Oct 22.
- Donnelly D, Everard MM, Chang AB. Indoor air modification interventions for prolonged non-specific cough in children. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD005075. doi: 10.1002/14651858.CD005075.pub2.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 12-10271
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Upper Respiratory Infection
-
Hanmi Pharmaceutical Company LimitedUnknownAcute Upper Respiratory Infection | Acute BronchitisKorea, Republic of
-
Daewon Pharmaceutical Co., Ltd.CompletedFever | Acute Upper Respiratory InfectionKorea, Republic of
-
Altesa Biosciences, Inc.Virtus Respiratory ResearchRecruitingRCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory InfectionInfections | Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Lung Diseases | Pulmonary Disease, Chronic Obstructive | Enterovirus Infections | Copd | Pulmonary Disease | Respiratory Disease | Respiratory Complication | Upper Respiratory Tract Infections | Respiratory Viral Infection | ... and other conditionsUnited Kingdom
-
China Academy of Chinese Medical SciencesGuangdong Provincial Hospital of Traditional Chinese Medicine; Guang'anmen... and other collaboratorsUnknownAcute Upper Respiratory InfectionChina
-
Reckitt Benckiser Inc.CompletedAcute Upper Respiratory Track InfectionUnited States
-
Guangzhou Yipinhong Pharmaceutical CO.,LTDCompletedAcute Upper Respiratory InfectionChina
-
Guangzhou Yipinhong Pharmaceutical CO.,LTDCompletedAcute Upper Respiratory InfectionChina
-
Nearmedic Plus LLCCompletedInfluenza | Acute Upper Respiratory InfectionRussian Federation
-
Nearmedic Plus LLCCompletedInfluenza | Acute Upper Respiratory InfectionArmenia, Georgia, Moldova, Republic of, Russian Federation
-
Materia Medica HoldingCompletedAcute Upper Respiratory InfectionsRussian Federation
Clinical Trials on Handheld humidifier
-
Tata Memorial HospitalCompleted
-
Birgitte Schantz LaursenFisher and Paykel Healthcare; AGA The Linde GroupCompleted
-
Lutheran Hospital, IndianaFisher and Paykel HealthcareUnknownChronic Obstructive Pulmonary Disease | COPDUnited States
-
Yonsei UniversityCompletedLung CancerKorea, Republic of
-
Institut für Pneumologie Hagen Ambrock eVResMed GmbH & Co KGCompleted
-
University Hospital, Clermont-FerrandCompletedLaparoscopic Hysteretctomy With PromontofixationFrance
-
Duke UniversityUniversity of Pennsylvania; National Institutes of Health (NIH)Not yet recruiting
-
Fisher and Paykel HealthcareCompleted
-
Fisher and Paykel HealthcareCompletedSleep Apnea, ObstructiveNew Zealand
-
Case Western Reserve UniversityCompleted